UK Healthcare vs Peer Nations — NHS Benchmark Tool [2026]

How This Tool Works

📋 Purpose

Headline NHS comparisons in the press are usually one-metric, one-year, one-peer caricatures — "Germany has more beds" or "the US spends more". The reality is more nuanced: the NHS leads peers on equity and financial protection, lags meaningfully on cancer survival and amenable mortality, and sits mid-pack on doctors and beds per 1000. This benchmark tool surfaces the OECD and Commonwealth Fund data in one place so policy researchers, journalists, NHS leaders and engaged citizens can compare the metrics that actually matter — PPP-adjusted spending, doctor density, cancer survival, waiting times and out-of-pocket spend — across a consistent reference year and a like-for-like peer set. Each metric ships with an explainer panel covering common pitfalls, so you can quote the figures with confidence and avoid the apples-to-oranges traps that catch out simple comparisons.

⚙️ How It Works

1
Pick comparison nations from the country chip group
2
Choose metric domain (spend, workforce, capacity, outcomes)
3
Read the hero metric card with UK rank
4
Inspect the bar chart and trend line
5
Read the plain-English metric explainer
6
Cross-check the source list and FAQ

Select health metric

Options

Split UK by nation (England, Scotland, Wales, NI)

Show 10-year trend

Select comparison nations

5/6 selected

Doctors per 1,000 Population Comparison

Doctors per 1,000 Population

Rank 5/6

2.9

per 1,000

vs OECD median:

-0.6 (-18.3%)

OECD median: 3.5 per 1,000

Understanding this metric

What it measures

Number of practicing physicians per 1,000 population. Indicates healthcare workforce capacity and access to medical care.

Data quality & comparability

WHO Global Health Workforce statistics. Definitions of 'practicing physician' vary slightly by nation.

Was this tool helpful?

Your quick feedback helps improve our tools

Complete Guide to UK Healthcare International Benchmarking

How to read OECD and Commonwealth Fund healthcare data, what spend-per-capita versus outcome metrics mean, and where the NHS genuinely leads or lags peer nations.

📅 Last updated: 2026-05-02

Quick Tips

Jump-start your understanding with these essential tips

Healthcare spend should be compared in Purchasing Power Parity (PPP) USD, not raw exchange rates, because medical wages and goods cost different amounts in different countries. The UK spent ~$5,490 PPP per capita in 2023 vs Germany ~$8,010 and the US ~$13,430.

Inputs (doctors per 1000, beds per 1000, % GDP spent) tell you the resources. Outputs (procedures, consultations) measure activity. Outcomes (life expectancy, cancer survival, amenable mortality) are what actually matters. The NHS scores well on equity, mid-pack on outcomes, and lower than peers on inputs.

5-year age-standardised cancer survival is the cleanest cross-country outcome. UK breast-cancer 5-year survival is ~85.6% vs Australia ~89.5% and Sweden ~88.9%. Lung cancer survival is ~16% in the UK vs ~22% in Germany. The gap is consistently 3-6 percentage points.

Out-of-pocket spend as % of total health expenditure is ~14% in the UK versus ~28% in France or ~13% in the Netherlands. Catastrophic health expenditure is rare in the UK because there are no copays for hospital care. This is a real strength rarely reported.

OECD data is published with a 1-2 year lag and country revisions can shift figures retrospectively. The tool fixes a single comparison year and labels it clearly. Avoid comparing UK 2024 figures to Germany 2022 figures — apples to oranges.

Step-by-Step Guide

Follow these steps to get the most from this tool

The country chip group lets you toggle Germany, France, Australia, Canada, Sweden, the Netherlands and Japan on or off. The UK is always shown as the reference. Pick 2-4 peer nations for the cleanest visual; more than that becomes hard to read.

Switch between Spending (per capita and % GDP), Workforce (doctors and nurses per 1000), Capacity (hospital beds, MRI/CT scanners per million), Outcomes (life expectancy, infant mortality, cancer survival) and Access (waiting times, OOP spend).

The hero card shows the UK's value, peer-nation values and the rank position (e.g. "UK ranks 6th of 7 on doctors per 1000"). Colour coding (green/amber/red) signals whether the UK is in the top, middle or bottom third for that metric.

The horizontal bar chart compares the selected metric across all chosen countries with a clear UK reference line. Hover any bar for the exact value, year and OECD source code.

The trend line plots 2010-2023 evolution so you can see whether the UK is converging towards or diverging from peers. NHS doctor density has grown but slower than Germany or Sweden over the period.

Each metric has a plain-English explainer covering what it measures, common pitfalls (e.g. "beds per 1000" is not adjusted for length of stay) and what good looks like. Use it to write balanced comparisons.

The FAQ addresses the common framing questions ("is the NHS good value?", "why is cancer survival lower?"). Sources are listed under each metric: OECD Health Statistics, Commonwealth Fund Mirror Mirror, ONS, NHS Digital and Eurostat.

Advanced Topics

Deep dives for advanced users

% GDP measures political prioritisation; per-capita PPP USD measures actual purchasing power for healthcare. The UK spends ~10.9% of GDP, which is mid-pack, but per-capita is below peer average because GDP per head is lower than Germany or Sweden. Both metrics matter and tell different stories.

Hospital beds per 1000 has fallen across all OECD countries because length of stay has fallen. The UK has 2.4/1000 vs Germany 7.8/1000 — but Germany also has 2x the average length of stay, so the bed-day capacity gap is smaller than the headline. Day-case rates and ambulatory care also matter.

Most of the UK cancer survival gap is explained by later stage at diagnosis, not worse treatment. UK lung-cancer patients are diagnosed at Stage 4 in ~46% of cases vs ~30% in Australia. Closing the diagnosis gap (faster GP referral, lower screening thresholds) would close most of the survival gap.

Different countries measure waiting times differently. UK 18-week RTT is consultant-led elective only. Germany has no national waiting target but median wait for elective surgery is ~12 days. Use the standardised Commonwealth Fund "% waited >2 months for specialist" measure for like-for-like comparisons.

For UK-specific drill-downs see the NHS ICB Prescribing Explorer, NHS Help with Health Costs Checker, and the UK 4-Nation Cost Comparator.

Frequently Asked Questions

Straight answers to common questions about this tool

On equity and financial protection the NHS consistently ranks 1st-2nd among 11 high-income countries (Commonwealth Fund Mirror Mirror). On health outcomes the NHS ranks 9th-10th. Overall, mid-table — strong system, weaker outcomes than spend would predict.

Mostly later diagnosis. UK patients present at later stages because of slower GP-to-specialist referral times and lower per-capita imaging capacity. Treatment outcomes once diagnosed are broadly comparable to peer nations.

OECD Health Statistics (annual), Commonwealth Fund Mirror Mirror, OECD HCQO indicators, ONS, NHS Digital and Eurostat. Each metric in the tool labels its source and reference year.

No. Most peer nations have copays. France copays ~30% before mutuelle insurance. Germany copays €10/day inpatient. Australia has Medicare bulk billing but copays for many GPs. The UK has no copays for primary or hospital care, which is unusual.

Yes — UK ~3.2 doctors per 1000 vs OECD average ~3.7. Germany 4.5, Sweden 4.3. The UK is recruiting and training more but the gap has been stable for over a decade.

Approximately £230-£250 billion per year across all 4 nations (NHS plus private), or about 10.9% of GDP and roughly £3,800 per person in cash terms (~$5,490 PPP).

Yes — total health expenditure (THE) includes public, social-insurance and private spending in all OECD figures. The "% public" line shows how much is government-funded.

On administrative cost share (~2% of total spend) the NHS is the most efficient large healthcare system in the OECD. On output per pound spent (procedures and consultations) it is mid-pack.

Depends on the metric. On equity: NHS or Norway. On outcomes: Australia, Sweden, Switzerland. On access speed: Germany. On overall Commonwealth Fund composite: Australia, Netherlands, UK have led different years. There is no single "best".

Latest OECD Health at a Glance reference year. Most metrics are 2022-2023 with a 1-2 year publication lag. The tool labels the reference year next to each value.

Other tools that pair well with this one